进入创新通道！供体灌注系统

Core Viewpoint - The article highlights the critical shortage of donor organs for transplantation globally, emphasizing the need for innovative solutions like the Life-D100 organ perfusion system developed by Qidian Medical to improve organ preservation and utilization [2][3][6]. Group 1: R&D Background - Over 1.5 million patients globally wait for organ transplants each year, with only about 20,000 surgeries performed annually in China despite 300,000 patients on the waiting list [2]. - Traditional organ preservation methods are limited, with liver preservation time under 12 hours and kidney under 24 hours, leading to increased surgical time pressure [2]. - China's organ donation rate is significantly lower than countries like Spain and the U.S., with only 4-5 donors per million people compared to Spain's 49.6 and the U.S.'s 40 [2]. Group 2: Product Introduction - The Life-D100 organ perfusion system maintains blood supply and normal physiological metabolism of donor organs through a continuous blood flow mechanism, avoiding damage from low temperatures and ischemia [6][9]. - The system includes a perfusion machine, pump drive device, and other components designed for ease of use and ergonomic comfort [8]. Group 3: Market Overview - The global organ transplantation market was valued at approximately $8 billion in 2023 and is projected to reach $15 billion by 2030, with a CAGR of about 9% [11]. - The organ donation rates vary significantly worldwide, with the U.S. and Europe leading, while Asian countries face lower rates, highlighting the urgent need to improve organ utilization [11]. - In China, the organ transplantation market is rapidly growing, with around 20,000 surgeries performed in 2023 and a market size exceeding 10 billion RMB [12]. Group 4: About Qidian Medical - Qidian Medical is a national high-tech enterprise focused on organ medicine and industrial development, with core technologies in non-ischemic organ transplantation and ex-vivo organ preservation [13]. - The company has developed several leading products in organ medicine, including the Life-X100 non-ischemic liver perfusion system, which addresses ischemia-reperfusion injury in organ transplantation [15].